.. Baylor Sammons Cancer Middle, Sarah Cannon, and Virginia Malignancy join Multiple Myeloma Analysis Consortium The Multiple Myeloma Study Consortium today announced that it has expanded its clinical research network to add Baylor Charles A. Sammons Malignancy Middle , Sarah Cannon /Analysis Institute and Virginia Cancer Professionals . These brand-new centers join the 13 existing MMRC Member Establishments to advertise and facilitating collaborative study and accelerating drug advancement in multiple myeloma, an incurable bloodstream cancer. To time, the MMRC offers advanced 27 early-stage scientific trials. MMRC Member Organizations donate to the MMRC Cells Bank also, which houses a crucial mass of highly-annotated bone marrow and peripheral bloodstream samples from multiple myeloma individuals, and acts as a bridge between laboratory and medical research.Collecting information or data to find patterns to track if changes are effective or not. Applying concepts of the psychology of modification to engage and encourage others to make the change. Initiating tests of alter or PDSA's that’s, plan, do, act and research. We're encouraging visitors to not only go to work to 'do their work' but also to 'enhance their work. This is what is needed to transform healthcare, Dolansky said.. Chemed board declares improved quarterly cash dividend Chemed Company announced today that the Panel of Directors has declared a quarterly cash dividend of 16-cents per share in the Company’s capital stock, on September 6 payable, 2011, of August 16 to shareholders of record since, 2011.